Seeking Alpha

jimmy Turano » Comments » Single Comment |

  • Alkermes, Lilly, Mannkind: Inhaled Insulin Just Got Interesting [View article]
    Mr.Shulman, your article regarding inhaled Insulin
    was quite interesting. I didn't know that there are two programs left to consider. Now that NVO is out and broke their agreement with 'NSTK' on Jan.16th
    according to yesterdays press release, do you think
    in your opinion that 'nstk' doesn't have any chances left in the inhaled insulin programs?
    Even though the stock price is down almost 80% in the past 12 months, you must admit the company has been around for 24 years already and management still keeps filing for shelf registrations and somebody keeps buying it.
    Jan 23 06:42 am |Rating: 0 0
All Comments by jimmy Turano »
Comments by Ticker
A, AA, AAPL, ABK, ABPIQ.PK, ABT, ABX, ACAD, ACCP.OB, ACOR, ACTC.PK, ACTU, ADAT, ADLS, ADLS.OB, AEM, AET, AEZS, AGEN, AGN, AGU, AIB, AIR, AIS, AKS, AL, ALKS, ALL, ALNY, ALPMF.PK, ALTH, ALTR, ALXN, AMAG, AMGN, AMLN, AMP, AMZN, ANDS, ANPI, AOB, APA, APOL, APWR, ARAY, ARDM.OB, ARIA, ARNA, ARQL, ARRY,
jimmy Turano's
Comments Stats
305 comments
Rating: 100 (213 - 113 )